The VC-to-IPO model dominates bio-economy discourse but not actual financing

Evidence

In the bio-economy, for example, the supposedly dominant business model is the VC-backed, dedicated life sciences firm looking for an IPO exit (Pina-Stranger and Lazega 2011); this is more in theory than reality, however, since most financing does not come from VC and most firms do not end up entering public markets (see Hopkins 2012; Hopkins et al. 2013; Birch forthcoming). — Kean Birch, Rethinking Value in the Bio-economy, 34

Categorization

• QUESTION: What does actually finance bio-economy firms if not VC? Worth chasing down Birch’s arguments since this bears directly on the assetization debate.
• XREF: connects to: Shareholder value operates as discourse disconnected from actual firm performance — Natascha van der Zwan, Making Sense of Financialization, 49; Early Silicon Valley startups IPO’d more but achieved profitability rarer than elsewhere — Shoshana Zuboff, The Age of Surveillance Capitalism, 1840; Netflix shares rose 13,000 percent in its first fifteen years since its 2002 IPO — Andrew deWaard, Derivative Media: How Wall Street…, 309

Related

• Early Silicon Valley startups IPO’d more but achieved profitability rarer than elsewhere (similarity 0.78)

Broader Connections

• Shareholder value operates as discourse disconnected from actual firm performance #corroborates (0.82) — Natascha van der Zwan, Making Sense of Financialization, 49
• Early Silicon Valley startups IPO’d more but achieved profitability rarer than elsewhere #exemplifies (0.75) — Shoshana Zuboff, The Age of Surveillance Capitalism, 1840
• Netflix shares rose 13,000 percent in its first fifteen years since its 2002 IPO #exemplifies (0.70) — Andrew deWaard, Derivative Media, 309